Involvement of Osteopontin in the Matrix-Degrading and Proangiogenic Changes Mediated by Nicotine in Pancreatic Cancer Cells

Journal of Gastrointestinal Surgery

Volumn 14, Issue 10, 2010, Pages 1566-1577

  Lazar, Melissa ^a   Sullivan, Jennifer ^a   Chipitsyna, Galina ^a   Gong, Qiaoke ^a   Ng, Chee Y ^a   Salem, Ahmed F ^a   Aziz, Tamer ^a   Witkiewicz, Agnes ^a   Denhardt, David T ^a   Yeo, Charles J ^a   Arafat, Hwyda A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Angiogenesis; Metastasis; MMP 9; Nicotine; Osteopontin; Pancreatic cancer; VEGF

Indexed keywords

CARCINOGEN; GELATINASE B; NICOTINE; OSTEOPONTIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOGENS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; NICOTINE; OSTEOPONTIN; PANCREATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957020956     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1338-0     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer Statistics, 2008. CA Cancer J Clin 2008; 52(2): 71-96.
2. Wang XL, Wang J. Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World Journal of Surgery 2005; 29: 344-53.
3. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Prac Res Clin Gastroenterology 2006; 20: 197-209.
4. US Department of Health and Human Services. The health consequences of using smokeless tobacco: a report of the advisory committee to the Surgeon General [NIH Publication no. 86-2874]. Bethesda, MD: USDHHS; April 1996.
5. Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and use of tobacco, alcohol and coffee. Intl J Cancer 1990; 45: 816-20.
6. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB et al. Cigarette smoking and pancreas cancer: a case control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510-6.
7. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89(17): 1260-70.
8. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3: 895-904.
9. Kelly T, Yan Y, Osborne RL, Athota AB, Rozypal TL, Colclasure JC, Chu WS. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis 1998; 16: 501-12.
10. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM, Pyrhonen S. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 2002; 97: 432-8.
11. Kahari VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumor growth and invasion. Ann Med 1999; 31: 34-45.
12. Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999; 43: 42-51.
13. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
14. Mira E, Lacalle RA, Buesa JM, de Buitrago GG, Jiménez-Baranda S, Gómez-Moutón C, Martínez-A C, Mañes S. Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci. 2004; 117(Pt 9): 1847-57.
15. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
16. Kerbel RS. Tumor angiogenesis. The New England Journal of Medicine 2008; 358(19): 2039-49.
17. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 1996; 2: 1679-84.
18. Takahashi Y, Kitadai Y, Bucana CD, Cleary ER, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res1995; 55: 3964-68.
19. Chipitsyna G, Gong Q, Anandanadesan R, Alnajar A, Batra SK, Denhardt ST, et al. Induction of osteopontin (OPN) expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells. Int J Cancer 2009; 125: 276-85.
20. Sullivan J, Blair L, Alnajar A, Aziz T, Ng CY, et al. Expression of a prometastatic splice variant of osteopontin, OPNc, in human pancreatic ductal adenocarcinoma. Surgery 2009; 146: 232-40.
21. Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang XW. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 2007; 26(44): 6361-71.
22. Liu J, Zhan M, Hannay JA, Das P, Bolshakov SV, Kotilingam D, Yu D, Lazar AF, Pollock RE, Lev D. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res. 2006 Nov; 4(11): 803-10.
23. Sánchez-López E, López AF, Esteban V, Yagüe S, Egido J, Ruiz-Ortega M, Alvarez-Arroyo MV. Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1alpha induction and redox mechanisms in the kidney. Antioxid Redox Signal. 2005; 7(9-10): 1275-84.
24. Liu H, Chen A, Guo F, Yuan L. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells. CancerLett. 2010; 295: 27-37.
25. Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene. 2009; 28(38): 3412-22.
26. Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 2008 Jan 1; 68(1): 152-61.
27. Tian M, Cui YZ, Song GH, Zong MJ, Zhou XY, Chen Y, Han JX. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer. 2008; 8: 241.
28. Mroczko B, Lukaszewicz-Zajac M, Wereszczynska-Siemiatkowska U, Groblewska M, Gryko M, Kedra B, Jurkowska G, Szmitkowski M. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor. Pancreas. 2009; 38(6): 613-8.
29. Toomey DP, Manahan E, McKeown C, Rogers A, McMillan H, Geary M, Conlon KC, Murphy JF. Vascular endothelial growth factor and not cyclooxygenase 2 promotes endothelial cell viability in the pancreatic tumor microenvironment. Pancreas. 2010; 39: 595-603.
30. Sandblom G, Granroth S, Rasmussen IC. TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head. Ups J Med Sci. 2008; 113(1): 57-64.
31. Hukkanen, J., Jacob, P. 3 rd and Benowitz, N. L. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005; 57: 79-115.
32. Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, et al. Osteopontin-c is a selective marker of breast cancer. Int J Cancer 2008; 122: 889-97.
33. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005; 9(4): 777-94.
34. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-61.
35. Rocca G, Gaia E, Iuliano R. Increased incidence of cancer in chronic pancreatitis. J Clin Gastroenterol. 1987; 9: 175-9.
36. Maisonnneuve P, Lowenfels AB. Chronic pancreatitis and pancreatic cancer. Dig Dis. 2002; 20: 32-7.